Mirati Therapeutics Eulerpool News

Mirati Therapeutics Eulerpool News

Mirati Therapeutics Aktie News

Mirati Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Mirati Therapeutics News stellen wir hier zusammen.

• 19. Januar ·

  Seeking Alpha
  Mirati Therapeutics ticks higher amid Nasdaq delisting for sale to Bristol-Myers
• 12. Januar ·

  Yahoo
  Insider Sell: EVP, Chief Commercial Officer Benjamin Hickey Sells Shares of Mirati Therapeutics Inc
• 12. Januar ·

  GuruFocus
  Insider Sell: EVP, Chief Commercial Officer Benjamin Hickey Sells Shares of Mirati Therapeutics Inc
• 11. Januar ·

  Yahoo
  Mirati (MRTX) Gets EU Nod for Krazati in KRAS-Mutated NSCLC
• 10. Januar ·

  Yahoo
  European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
• 10. Januar ·

  Seeking Alpha
  Mirati's Krazati gets EU conditional approval for lung cancer
• 10. Januar ·

  Thefly.com
  Mirati Therapeutics receives conditional authorization for KRAZATI from EC
• 8. Januar ·

  Seeking Alpha
  Bristol-Myers looking for smaller deals after 2023 shopping spree: report
• 7. Januar ·

  SeekingAlpha
  Tango Therapeutics Must Produce Its Own Data To Justify Its Valuation
• 3. Januar ·

  Thefly.com
  The biopharmaceuticals stocks to own in 2024, according to BofA